| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-05 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0001 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
| mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.0003 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |